DoharJE, KennaMA, WadowskyRM. In vitro susceptibility of aural isolates of Pseudomonas aeruginosa to commonly used ototopical antibiotics. Am J Otol1996;17:207–9.
PooleMD. Amathematical therapeutic outcomes model for sinusitis. Otolaryngol Head Neck Surg2004;130(1 suppl):46–50.
5.
AnonJB, JacobsMR, PooleMD, etal; Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg2004;130(1 suppl):1–45.
6.
RuoholaA, HeikkinenT, MeurmanO, Antibiotic treatment of acute otorrhea through tympanostomy tube: Randomized double-blind placebo-controlled study with daily follow-up. Pediatrics2003;111(5 pt 1):1061–7.
7.
DoharJE, GarnerET, NielsenRW, Topical ofloxacin treatment of otorrhea in children with tympanostomy tubes. Arch Otolaryngol Head Neck Surg1999;125:537–45.
8.
ShinSH, PonikauJU, SherrisDA, Chronic rhinosinusitis: An enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol2004;114:1369–75.
9.
SpandowO, HellstromS.Animal model for persistent tympanic membrane perforations. Ann Otol Rhinol Laryngol1993;102:467–72.
RolandPS, KreislerLS, ReeseB, Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics2004;113:e40–6.
12.
DoharJE, KennaMA, WadowskyRM. Therapeutic implications in the treatment of aural Pseudomonas infections based on in vitro susceptibility patterns. Arch Otolaryngol Head Neck Surg1995;121:1022–5.
13.
RolandPS, StewartMG, HannleyM, Consensus panel on role of potentially ototoxic antibiotics for topical middle ear use: Introduction, methodology, and recommendations. Otolaryngol Head Neck Surg2004;130(suppl):S51–6.
